Enrofloxacin—The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?
Top Cited Papers
Open Access
- 26 March 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3648
Abstract
Enrofloxacin is a compound that originates from a group of fluoroquinolones that is widely used in veterinary medicine as an antibacterial agent (this antibiotic is not approved for use as a drug in humans). It reveals strong antibiotic activity against both Gram-positive and Gram-negative bacteria, mainly due to the inhibition of bacterial gyrase and topoisomerase IV enzymatic actions. The high efficacy of this molecule has been demonstrated in the treatment of various animals on farms and other locations. However, the use of enrofloxacin causes severe adverse effects, including skeletal, reproductive, immune, and digestive disorders. In this review article, we present in detail and discuss the advantageous and disadvantageous properties of enrofloxacin, showing the benefits and risks of the use of this compound in veterinary medicine. Animal health and the environmental effects of this stable antibiotic (with half-life as long as 3–9 years in various natural environments) are analyzed, as are the interesting properties of this molecule that are expressed when present in complexes with metals. Recommendations for further research on enrofloxacin are also proposed.Keywords
Funding Information
- Institute of Biochemistry and Biophysics, Polish Academy of Sciences (SBM-04/21, PN-32)
This publication has 176 references indexed in Scilit:
- Fluoroquinolone-Mediated Inhibition of Cell Growth, S-G2/M Cell Cycle Arrest, and Apoptosis in Canine Osteosarcoma Cell LinesPLOS ONE, 2012
- Modulation of enrofloxacin binding in OmpF by Mg2+ as revealed by the analysis of fast flickering single-porin currentJournal of General Physiology, 2012
- Evaluation of the Efficacy and Safety of High Dose Short Duration Enrofloxacin Treatment Regimen for Uncomplicated Urinary Tract Infections in DogsJournal of Veterinary Internal Medicine, 2012
- Mechanisms for Defining Supercoiling Set Point of DNA Gyrase OrthologsJournal of Biological Chemistry, 2012
- Synchronous fluorescence measurement of enrofloxacin in the pharmaceutical formulation and its residue in milks based on the yttrium (III)-perturbed luminescenceTalanta, 2010
- How antibiotics kill bacteria: from targets to networksNature Reviews Microbiology, 2010
- Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell deathJournal of Antimicrobial Chemotherapy, 2010
- The effect of enrofloxacin on sperm quality in male miceResearch in Veterinary Science, 2008
- Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying EnzymeAntimicrobial Agents and Chemotherapy, 2006
- DNA Gyrase and Topoisomerase IV on the Bacterial Chromosome: Quinolone-induced DNA CleavageJournal of Molecular Biology, 1996